About
ABK Biomedical Inc. is a clinical-stage medical device company based in Halifax, Nova Scotia, with an additional office in Ladera Ranch, California. The company specializes in the research, development, and commercialization of innovative embolotherapy products aimed at treating benign and malignant hypervascular tumors, particularly liver tumors. The core technology of ABK Biomedical is its proprietary Eye90 microspheres®, which utilize Yttrium-90 (Y90) radioembolization combined with a unique imageable glass composition. This technology enhances visualization during procedures, improving tumor targeting and dosimetry precision. The company develops inorganic polymer microspheres and bland embolic products designed for embolization therapies, operating its own R&D and manufacturing facilities to support these efforts. ABK Biomedical primarily serves medical professionals and institutions in interventional radiology and oncology, focusing on improving treatment outcomes for patients with hypervascular tumors.
Technologies
Keywords
Company Information
-
Employees 42
-
Founded 2012
-
Annual Revenue $8000000
-
Total Funding $63000000
Location
155 Chain Lake Drive, Halifax, Nova Scotia, Canada, B3S 1B3